Expert Consensus on the Significance of Intravenous Iron using Ferric Carboxymaltose Perioperatively and in Elective Major Orthopedic Surgeries

/in /by

Journal of Clinical Orthopaedics | Vol 9 | Issue 1 |  January-June 2024 | page: 42-51 | Mohan Desai, Punit Jain, Surendar Singh Bava, Swarnendu Samanta, K R Prathap Kumar, Anand Galagali, Santhosh Shetty, Atul Panghate, Ashish Arbat, Satish Sonar, Attique Vasdev, Prashant Tonape, Miten Sheth, Ashraf Shaikh, Sachin Suryawanshi, Ketan Kulkarni

DOI: https://doi.org/10.13107/jcorth.2024.v09i01.000

Author: Mohan Desai [1], Punit Jain [2,3], Surendar Singh Bava [1], Swarnendu Samanta [4], K R Prathap Kumar [5], Anand Galagali [6], Santhosh Shetty [7], Atul Panghate [1], Ashish Arbat [8,9], Satish Sonar [10], Attique Vasdev [11], Prashant Tonape [12], Miten Sheth [13], Ashraf Shaikh [1], Sachin Suryawanshi [14], Ketan Kulkarni [15]

[1] Department of Orthopedics, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India,
[2] Department of Hematology Oncology and Stem Cell Transplant, Apollo Hospitals, Navi Mumbai, Maharashtra, India,
[3] HematCare-Speciality Hematology Clinic, Powai, Mumbai, India,
[4] Department of Orthopedics, Peerless Hospital, Kolkata, West Bengal, India,
[5] Department of Orthopedics, Sunrise Group of Hospitals, Kochi, Kerala, India,
[6] Department of Orthopedics Surgery Manipal Hospital, Bengaluru, Karnataka, India,
[7] Department of Arthroplasty and Joint Replacement, Surana Group of Hospitals, Malad, Mumbai, Maharashtra, India,
[8] Department of Joint Replacement Surgery, Jehangir Hospital, Pune, Maharashtra, India,
[9] Department of Orthopedics, Oyster and Pearl Hospital, Pune, Maharashtra, India,
[10] SportsMed Arthroscopy and Shoulder Surgery Centre, Nagpur, Maharashtra, India,
[11] Department of Orthopaedics, Institute of Musculoskeletal Disorders and Orthopaedics, Medanta – The Medicity, Gurugram, Haryana, India,
[12] Department ofArthroscopy and Joint Replacement Surgery, Sterling Multispeciality Hospital, Nigadi, Pradhikaran, Pune, Maharashtra, India,
[13] The Knee Clinic, Mumbai, Maharashtra, India,
[14] Medical Services, Emcure Pharmaceuticals Ltd, Mumbai, Maharashtra, India,
[15] Medical Services, Emcure Pharmaceuticals Ltd, Pune, Maharashtra, India.

Address of Correspondence
Dr. Ketan Kulkarni,
Medical Services, Emcure Pharmaceuticals Ltd, Pune, Maharashtra, India.
E-mail: Ketan.Kulkarni@emcure.com

Abstract

Anemia has emerged as a significant healthcare crisis in India and often remains undiagnosed, with broad implications across all age groups. Iron deficiency remains the most important and correctable cause of anemia in our country. It often leads to significant morbidity during major operative procedures such as hip and knee arthroplasties, due to the substantial intraoperative bleeding associated with these procedures. To address this challenge and mitigate complications related to blood transfusions, peri-operative iron therapy, notably parenteral iron therapy, has become common practice. Nevertheless, there is a lack of consensus on managing peri-operative anemia and the role of ferric carboxymaltose (FCM) in pre-operative and post-operative orthopedic surgeries in India. A group of 14 experts, primarily orthopedic surgeons and an hematologist in India, convened an in-person expert group meeting. Their primary focus was on the approach of FCM in managing anemia in elective orthopedic surgeries within the diverse landscape of the Indian healthcare system. The consensus strongly advocated using FCM as a rapid and adequate source of iron replacement, especially in cases of significant pre-operative and post-operative anemia in patients undergoing elective orthopedic surgery.
Keywords: Pre-operative, post-operative, orthopedic surgery, anemia, ferric carboxymaltose.

References

1. Scott S, Lahiri A, Sethi V, De Wagt A, Menon P, Yadav K, et al. Anaemia in Indians aged 10-19 years: Prevalence, burden and associated factors at national and regional levels. Matern Child Nutr 2022;18:e13391.
2. Natekar P, Deshmukh C, Limaye D, Ramanathan V, Pawar A. A micro review of a nutritional public health challenge: Iron deficiency anemia in India. Clin Epidemiol Glob Health 2022;14:100992.
3. Gani A, Bhat S, Gupta A. Pattern and prevalence of orthopaedic outdoor patients at a tertiary level care hospital in Jammu, India. JK Sci 2016;18:155-8.
4. Bhandarkar P, Priti P, Chander S, Nandan K. Prevalence of osteoarthritis knee: Four year study based on digital records of comprehensive healthcare setup at Mumbai, India. Int J Community Med Public Health 2016;3:1049-53.
5. Vaidya SV, Jogani AD, Pachore JA, Armstrong R, Vaidya CS. India Joining the World of hip and knee registries: Present status-a leap forward. Indian J Orthop 2020;55 Suppl 1:46-55.
6. Bisbe E, Basora M, Colomina MJ, Spanish Best Practice in Peri-Operative Anaemia Optimisation Panel. Peri-operative treatment of anaemia in major orthopaedic surgery: A practical approach from Spain. Blood Transfus 2017;15:296-306.
7. Spahn DR. Anemia and patient blood management in hip and knee surgery: A systematic review of the literature. Anesthesiology 2010;113:482-95.
8. Theusinger OM, Leyvraz PF, Schanz U, Seifert B, Spahn DR. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: Efficacy and limits: A prospective study. Anesthesiology 2007;107:923-7.
9. Phan K, Dunn AE, Kim JS, Di Capua JD, Somani S, Kothari P, et al. Impact of Preoperative anemia on outcomes in adults undergoing elective posterior cervical fusion. Global Spine J 2017;7:787-93.
10. Gómez-Ramirez S, Jericó C, Muñoz M. Peri-operative anemia: Prevalence, consequences and pathophysiology. Transfus Apher Sci 2019;58:369-74.
11. Muñoz M, Gómez-Ramírez S, Campos A, Ruiz J, Liumbruno GM. Pre-operative anaemia: Prevalence, consequences and approaches to management. Blood Transfus 2015;13:370-9.
12. Cançado RD, De Figueiredo PO, Olivato MC, Chiattone CS. Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia. Rev Bras Hematol Hemoter 2011;33:439-43.
13. Arakawa N, Bader LR. Consensus development methods: Considerations for national and global frameworks and policy development. Res Soc Adm Pharm 2022;18:2222-9.
14. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: Blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003;43:459-69.
15. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: Analysis of predictive factors. J Bone Joint Surg Am 2002;84:216-20.
16. Basora M, Tió M, Martin N, Lozano L, Salazar F, Sánchez-Etayo G, et al. Should all patients be optimized to the same preoperative hemoglobin level to avoid transfusion in primary knee arthroplasty? Vox Sang 2014;107:148-52.
17. Available from: https://main.mohfw.gov.in/sites/default/files/nfhs-5_phase-II_0.pdf [Last accessed on 2023 Aug 31].
18. Anemia Mukt Bharat. Available from: https://anemiamuktbharat.info [Last accessed on 2023 Oct 18].
19. Song JH, Park JW, Lee YK, Kim IS, Nho JH, Lee KJ, et al. Management of blood loss in hip arthroplasty: Korean hip society current consensus. Hip Pelvis 2017;29:81-90.
20. BBTS-NATA (Network for the Advancement of Transfusion Alternatives). Available from: https://www.bbts.org.uk/events/bbts_events/natanetwork_for_the_advancement_of_transfusion_alternatives [Last accessed on 2023 Oct 27].
21. Umesh G, Bhaskar SB, Harsoor SS, Dongare PA, Garg R, Kannan S, et al. Preoperative investigations: Practice guidelines from the Indian society of anaesthesiologists. Indian J Anaesth 2022;66:319-43.
22. Okam MM, Koch TA, Tran MH. Iron supplementation, response in iron-deficiency anemia: Analysis of five trials. Am J Med 2017;130:991.e1-8.
23. Available from: https://www.fogsi.org/wp-content/uploads/2017/07/gcpr-recommendation-ida.pdf [Last accessed on 2023 Aug 31].
24. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P. Peri-operative anaemia management: Consensus statement on the role of intravenous iron. Br J Anaesth 2008;100:599-604.
25. Wong LP, Lee HY, Khor CS, Abdul-Jamil J, Alias H, Abu-Amin N, et al. The risk of transfusion-transmitted hepatitis E virus: Evidence from seroprevalence screening of blood donations. Indian J Hematol Blood Transfus 2022;38:145-52.
26. Auerbach M, Ballard H. Clinical use of intravenous iron: Administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program 2010;2010:338-47.
27. Qunibi WY. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: A review. Arzneimittelforschung 2010;60:399-412.
28. Jahn MR, Andreasen HB, Fütterer S, Nawroth T, Schünemann V, Kolb U, et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. Eur J Pharm Biopharm 2011;78:480-91.
29. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: Systematic review and meta-analysis of randomised clinical trials. BMJ 2013;347:f4822.
30. Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose: A review of its use in iron-deficiency anaemia. Drugs 2009;69:739-56.
31. Bailie GR. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: A review of randomized controlled trials across different indications. Arzneimittelforschung 2010;60:386-98.
32. Friedrisch JR, Cançado RD. Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia. Rev Bras Hematol Hemoter 2015;37:400-5.
33. Geisser P, Banké-Bochita J. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: A dose-escalation study in volunteers with mild iron-deficiency anaemia. Arzneimittelforschung 2010;60:362-72.
34. Vikrant S, Parashar A. The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center study. Indian J Nephrol 2015;25:213-21.
35. Bailie GR, Mason NA, Valaoras TG. Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Hemodial Int 2010;14:47-54.
36. Moore RA, Gaskell H, Rose P, Allan J. Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. BMC Blood Disord 2011;11:4.
37. Covic A, Mircescu G. The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: A multi-centre, open-label, clinical study. Nephrol Dial Transplant 2010;25:2722-30.
38. Bisbe E, Moltó L, Arroyo R, Muniesa JM, Tejero M. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. Br J Anaesth 2014;113:402-9.
39. Park HS, Bin SI, Kim HJ, Kim J, Kim H, Ro Y, et al. Immediate intravenous iron administration improves anaemia recovery following total knee arthroplasty: A propensity-matched analysis. Vox Sang 2022;117:243-50.
40. Smith A, Moon T, Pak T, Park B, Urman RD. Preoperative anemia treatment with intravenous iron in patients undergoing major orthopedic surgery: A systematic review. Geriatr Orthop Surg Rehabil 2020;11:2151459320935094.
41. Maniar AR, Mishra A, Sanghavi N, Maniar RN. Does postoperative intravenous ferric carboxymaltose hasten the recovery of hemoglobin in patients post total knee arthroplasty? J Arthroplasty 2022;37:S155-8.
42. Kim MS, Koh IJ, Choi KY, Yang SC, In Y. Efficacy and safety of intravenous ferric carboxymaltose in patients with postoperative anemia following same-day bilateral total knee arthroplasty: A randomized controlled trial. J Clin Med 2021;10:1457.
43. Choi KY, Koh IJ, Kim MS, Kim C, In Y. Intravenous ferric carboxymaltose improves response to postoperative anemia following total knee arthroplasty: A prospective randomized controlled trial in Asian cohort. J Clin Med 2022;11:2357.
44. Jones JJ, Mundy LM, Blackman N, Shwarz M. Ferric carboxymaltose for anemic peri-operative populations: A systematic literature review of randomized controlled trials. J Blood Med 2021;12:337-59.
45. Suh YS, Nho JH, Seo J, Jang BW, Park JS. Hip fracture surgery without transfusion in patients with hemoglobin less than 10 g/dL. Clin Orthop Surg 2021;13:30-6.
46. Manosroi W, Atthakomol P, Isaradech N, Phinyo P, Vaseenon T. Preoperative correction of low hemoglobin levels can reduce 1-year all-cause mortality in osteoporotic hip fracture patients: A retrospective observational study. Clin Interv Aging 2022;17:165-73.
47. Lin Y. Preoperative anemia-screening clinics. Hematology Am Soc Hematol Educ Program 2019;2019:570-6.
48. Manjuladevi M, Vasudeva Upadhyaya K. Perioperative blood management. Indian J Anaesth 2014;58:573-80.
49. Sultan S, Zaheer HA, Waheed U, Baig MA, Rehan A, Irfan SM. Internal quality control of blood products: An experience from a tertiary care hospital blood bank from Southern Pakistan. J Lab Physicians 2018;10:64-7.
50. Park HS, Bin SI, Kim HJ, Kim TY, Kim J, Kim H, et al. Short-term high-dose intravenous iron reduced peri-operative transfusion after staggered bilateral total knee arthroplasty: A retrospective cohort study. Vox Sang 2022;117:562-9.

How to Cite this article: Desai M, Jain P, Bava S, Samanta S, Kumar KRP, Galagali A, Shetty S, Panghate A, Arbat A, Sonar S, Vasdev A, Tonape P, Sheth M, Shaikh A, Suryawanshi S, Kulkarni K. Expert Consensus on the Significance of Intravenous Iron using Ferric Carboxymaltose Perioperatively and in Elective Major Orthopedic Surgeries. Journal of Clinical Orthopaedics 2024 January-June;9(1):42-51.

 (Article Text HTML)       (Download PDF)